Jubilant Innovation (India) Limited
About Jubilant Innovation (India) Limited
Data last updated:
Jubilant Innovation (India) Limited was a public limited company based in Noida, Uttar Pradesh, India, operated as a subsidiary of Drug Discovery And Development Solutions Limited. The company has been dissolved (liquidated) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 29 November 2007.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U73100UP2007PLC034211. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It was led by directors including Sankaraiah Rajagopal and Benny Thomas.
Its last annual general meeting (AGM) was held on 25 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2018, the company reported a revenue of ₹49,000, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹36,000 (net margin -73.5%) and EBITDA of -₹36,000 (EBITDA margin -73.5%).
The company was associated with 1 brand: Jubilant Life Sciences.
Company details
Contact details
Jubilant Innovation (India) Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301
- IndustryLife Sciences, Biotechnology
To see the full contact details of Jubilant Innovation (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Jubilant Innovation (India) operates one associated brand: Jubilant Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Company offering a suite of R&D and manufacturing services for small molecules and generics | jubl.com |
Business activity
The main business activity of Jubilant Innovation (India) is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Jubilant Innovation (India) Limited, buy the company report.
Financials of Jubilant Innovation (India) Limited
FY 2018 filings availableJubilant Innovation (India) Limited reported revenue of ₹49,000 (down 66% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 66% in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹49,000 | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹36,000 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹36,000 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -73.5% | |||
| Net Profit Margin | -73.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Jubilant Innovation (India) Limited, buy the company report.
Board of directors of Jubilant Innovation (India) Limited
Jubilant Innovation (India) has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sankaraiah Rajagopal Also directs: Strafin Solutions LLP, Continental Advance System (India) Limited, Baxy Engineering Limited and 4 more | Director | 29 Nov 2007 | 18 Years 10 Months | As last reported |
| Arun Kumar Sharma Also directs: Jubilant Clinsys Limited, Jubilant First Trust Healthcare Limited, Jubilant Draximage Limited and 1 more | Additional Director | 29 Apr 2019 | 7 Years 5 Months | As last reported |
| Benny Thomas Also directs: Sami Nutraceuticals Private Limited | Director | 29 Jan 2016 | 10 Years 8 Months | As last reported |
Peer comparison
Jubilant Innovation (India) Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Evolva Biotech Private Limited | ₹57,246 (FY 2020) | -98.0% | Chennai, Tamil Nadu, India | |||
| Jubilant Innovation (India) Limitedthis company | ₹49,000 (FY 2018) | -₹36,000 | -73.5% | -66.0% | Noida, Uttar Pradesh, India | |
| Genophe Biotech Private Limited | ₹44,240 (FY 2024) | -97.0% | Bangalore, Karnataka, India | |||
| Aeka Biochemicals Private Limited | ₹42,373 (FY 2024) | -92.0% | Thiruvananthapuram, Kerala, India | |||
| Igy Immunologix India Private Limited | ₹42,000 (FY 2025) | -98.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Jubilant Innovation (India) Limited, buy the company report.
Auditor
Jubilant Innovation (India) Limited is audited by B S R & CO LLP for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & CO LLP | FY 2018 | 101248W |
Shareholding
The shareholding of Jubilant Innovation (India) Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Jubilant Innovation (India) Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jubilant Innovation (India) Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jubilant Innovation (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jubilant Innovation (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Jubilant Innovation (India) Limited, buy the company report.
Recent activity
Jubilant Innovation (India) Limited has 11 board changes on record since 2007: 3 appointments and 8 cessations. The latest: Arun Kumar Sharma was appointed as Additional Director on 29 Apr 2019.
2 earlier events are in the company report.
Frequently asked questions
Jubilant Innovation (India) has been "Dissolved (Liquidated)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Jubilant Innovation (India) was a public limited company based in Noida, Uttar Pradesh, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 29 November 2007 and is registered under CIN U73100UP2007PLC034211. The company is recorded as dissolved (liquidated) in MCA records and no longer exists as a legal entity.
Jubilant Innovation (India) was incorporated on 29 November 2007. It is registered with the Registrar of Companies, Kanpur.
Jubilant Innovation (India) had 3 directors:
- Sankaraiah Rajagopal - Director
- Arun Kumar Sharma - Additional Director
- Benny Thomas - Director
The CIN (Corporate Identification Number) of Jubilant Innovation (India) is U73100UP2007PLC034211. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Jubilant Innovation (India) is at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.
The latest financial statements of Jubilant Innovation (India) on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 25 September 2018. Year-wise statements from 2015 are in the company report.
No. Jubilant Innovation (India) has 1 GST registration on record and it is cancelled or inactive.
Jubilant Innovation (India) operated in the life sciences industry, in the biotechnology segment.
The peers of Jubilant Innovation (India) by revenue are Evolva Biotech Private Limited, Genophe Biotech Private Limited, Aeka Biochemicals Private Limited, Igy Immunologix India Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development).
Arun Kumar Sharma was appointed as Additional Director on 29 Apr 2019. Ashutosh Agarwal ceased to be Director on 29 Apr 2019. Benny Thomas ceased to be Additional Director on 17 Aug 2016. Jubilant Innovation (India) has 11 board changes on record in total.